Phenotypic and functional characterization of mobilized peripheral blood CD34+ cells coexpressing different levels of c-Kit

Leukemia Research

Volumn 22, Issue 4, 1998, Pages 355-363

  Kuçi, Selim ^a   Taylor, Gwendolyn ^a   Neu, Stefan ^a   Schumm, Michael ^a   Niethammer, Dietrich ^a   Handgretinger, Rupert ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

CD117 (c Kit); Ex vivo expansion; Immunophenotyping; Mobilized peripheral blood CD34+ cells; Progenitor cell assay; Reactive oxygen intermediates

Indexed keywords

MONOCLONAL ANTIBODY; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR;

ARTICLE; CELL FRACTIONATION; CLONOGENIC ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; PERIPHERAL BLOOD STEM CELL; PHENOTYPE; PRIORITY JOURNAL; STEM CELL;

ANTIGENS, CD2; ANTIGENS, CD34; ANTIGENS, CD7; CELL SEPARATION; COLONY-FORMING UNITS ASSAY; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; LEUKOCYTES, MONONUCLEAR; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-KIT; REACTIVE OXYGEN SPECIES; TIME FACTORS;

EID: 0032052794     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(98)00002-2     Document Type: Article

References (40)

1. [1] Majunder M, Brown K, Qiu F-H, Besmer P. c-Kit protein, a transmembrane kinase: identification in tissues and characterization. Mol Cell Biol 1988;8:4896.
2. [2] Qui F, Brown K, Barker PE, Jhanwar S, Ruddle RH, Besmer P. Relationship with the CSF-1/PDGF receptor kinase family-oncogenic activation of v-kit involves deletion of extracellular domain and terminus. EMBO J 1988;7:1003.
3. [3] Yarden Y, Kuang WJ, Yang-Feng T, Coussens L, Manemitsu S, Dull TJ, Chen E, Schlessinger J, Franke U, Ullrich A. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 1987;6:3341.
4. [4] Martin FH, Suggs SV, Langley KE, Lu HS, Ting J, Okino KH, Morris CF, McNiece IF, Jacobsen FW, Mendiaz EA, Birkett NC, Smith KA, Johnson MJ, Parker VP, Flores JC, Patel AC, Fisher EF, Erjavec HO, Herrera CJ, Wypych J, Sachdev RK, Pope JA, Leslie I, Wen D, Lin C-H, Cupples RL, Zsebo KM. Primary structure and functional expression of rat and human stem cell factor DNAs. Cell 1990;63:203.
5. [5] Zsebo KM, Williams DA, Geissler EN, Broudy VC, Martin FH, Atkins HL, Hus R-Y, Birkett NC, Okino KM, Murdock DC, Jacobsen FW, Langley KE, Smith KA, Takeishi T, Cattanach BM, Galli SJ, Suggs SV. Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 1990;63:213.
6. [6] Anderson DM, Lyman SD, Baird A, Wignall LM, Eisenman J, Rauch C, March CJ, Bosswell HS, Gimpel SD, Cosman D, Williams DE. Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell 1990;63:235.
7. [7] Chabot B, Stephenson DA, Chapman VM, Besmer P, Bernstein A. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature 1988;335:88.
8. [8] Geissler EN, Ryan MA, Housman DE, The dominant-white spotting locus of the mouse encodes the c-kit proto-oncogene. Cell 1988;55:185.
9. [9] Huang E, Nocka K, Beier DR, Chu TY, Buck J, Lahm HW, Wellner D, Leder P, Besmer P. The hematopoetic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus. Cell 1990;63:225.
10. [10] Flanagan JG, Leder P. The kit ligand: a cell surface molecule altered in steel mutant fibroblasls. Cell 1990;63:185.
11. [11] Copeland NG, Gilbert DJ, Cho BC, Donovan PJ, Jenkins NA, Cosman D, Anderson D, Lyman SD. Williams DE. Mast cell growth factor maps near the steel iocus on mouse chromosome 10 and is deleted in a number of steel alleles. Cell 1990;63:175.
12. high cells. Blood 1993;82:3283.
13. [13] De Jong MO, Wagemaker G. Wognum AW. Separation of myeloid and erythroid progenitors based on expression of CD34 and c-kit. Blood 1995;86:4076.
14. [14] Katayama N, Shih J., Nishikawa S, Kina T, Clark S, Ogawa M. Stage-specific expression of c-kit protein by murine hematopoietic progenitors. Blood 1993;82:2353.
15. [15] Laver JH, Abboud MR, Kawashima I, Leary AG, Ashman LK, Ogawa M. Characterization of c-kit expression by primitive hematopoietic progenitors in umbilical cord blood. Exp Hematol 1996;24:285.
16. + human marrow cells that express low levels of kit protein are enriched for long-term marrow-engrafting cells. Blood 1996;87:4136.
17. [17] Bühring HJ, Ullrich A, Schaudt K, Müller CA, Busch FW. The product of the proto-oncogene c-kit (P 145 c-kit) is a human bone marrow surface antigen of hematopoietic precursor cells which is expressed on a subset of acute non-lymphoblastic leukemic cells. Leukemia 1991;5:854.
18. [18] Lerner NB, Nocka KH, Cole SR, Strife A, Ashman LK, Besmer P. Monoclonal antibody YB5.B8 identifies the human c-kit protein product. Blood 1991;77:1876.
19. [19] Reuss-Borst MA, Bühring HJ, Schmidt H, Müller CA. AML: immunophenotypic heterogeneity and prognostic significance of c-kit expression. Leukemia 1994;8:258.
20. [20] Wang C, Curtis JE, Geissler EN, McCulloch EA. Minden MD. The expression of the proto-oncogene c-kit in the blast cells of acute myeloblastic leukemia. Leukemia 1989;3:699.
21. [21] Breems DA, Blokland EAW, Neben S, Ploemacher RE. Frequency analysis of human primitive haematopoietic stem cell subsets using a cobble stone area forming cell assay. Leukemia 1994;8:1095.
22. [22] Ploemacher RE, Van der Sluijs JP, Voerman JSA, Brons NHC. An in vitro limiting-dilution assay of long-term repopulating hematopoietic stem cells in the mouse. Blood 1989;74:2755.
23. [23] Ogawa M, Shih JP, Katayama N. Enrichment for primitive hemopoietic progenitors of marrow cells from 5-fluorouracil-treated mice and normal mice. Blood Cells 1994;20:7.
24. [24] Ikuta K, Weissman IL. Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. Proc Natl Acad Sci USA 1992;89:1502.
25. [25] Okada S, Nakauchi H, Nagayoshi K, Nishikawa S, Miura Y, Suda T. In vivo and in vitro stem cell function of c-kit-and Sea-1-positive murine hematopoietic cells. Blood 1992;80:3044.
26. [26] Okada S. Nakauchi H, Nagayoshi K, Nishikawa S, Miura Y, Suda T. Enrichment and characterization of murine hematopoietic stem cells that express c-kit molecule. Blood 1991;78:1706.
27. [27] Ashman LK, Cambareri AC, To LB, Levinsky RJ, Juttner CA. Expression of the YB5.B8 antigen (c-kit proto-oncogene product) in normal human bone marrow. Blood 1991;78:30.
28. [28] Simmons PJ, Aylett GW, Niutta S, To LB, Juttner CA, Ashman LK. c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture. Exp Hematol 1994;22:157.
29. + cells. Blood 1994;84:2930.
30. + hematopoietic progenitor cells: comparison of cytokine-mobilized blood stem cells with normal bone marrow and peripheral blood. J Hematother 1993;2:483.
31. high cells in which transforming growth factor-beta (TGF-beta) downmodutates c-kit and KIT1™ cells in which anti-TGF-beta upmodulates c-kit. Blood 1995;86:1729.
32. + cells via p55 TNF alpha receptors. Blood 1994;84:2506.
33. + into the myeloid lineage. Blood 1992;80:1405.
34. + -selected human peripheral blood progenitor cells. Blood 1994;84:2898.
35. + progenitor cells by stem cell factor, interleukin-1β (IL-1β), IL-6, IL-3, interferonγ-, and erythropoietin. Blood 1993;81:2579.
36. [36] Korbling M, Dorken B, Ho AD, Pezzuta A, Hunstein W, Fliedner TM. Autologous transplanation of blood-derived hemopoietic stem cells after myeloablative therapy in a patient with Burkitt's lymphoma. Blood 1986;67:529.
37. [37] Bell AJ, Hamblin TJ, Oscier DG. Circulating stem cell autograft. Bone Marrow Transplant 1986;1:103.
38. [38] Muroi K, Nakamura M, Amemiya Y, Suda T, Miura Y. Expression of c-kit receptor (CD117) and CD34 in leukemic cells. Leuk Lymphoma 1995;16:297.
39. [39] Kubota A, Okamura S, Shimoda K, Harada M, Niho Y. The c-kit molecule and the surface immunophenotype of human acute leukemia. Leuk Lymphoma 1994;14:421.
40. [40] Drach D, Estrov Z, Zhao S, Drach J, Cork A, Collins D, Kantarjian H, Andreff M. Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia. Leuk Lymphoma 1994;16:79.